Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Osteoporosis Research, Prevention Steps Outlined By NIH Panel

This article was originally published in The Tan Sheet

Executive Summary

A National Institutes of Health draft consensus statement points to the "urgent need" for future study of combination therapy, including dietary supplements, for osteoporosis.

You may also be interested in...



Calcium, Vitamin D Role In Osteoporosis Needs Further Study - IoM

Better dose-response data are required for determining the lowest levels of calcium and vitamin D supplements needed to prevent and treat osteoporosis and to examine interactions between the nutrients and estrogen, the Institute of Medicine advises.

Calcium/vitamin D reduces bone loss, fractures in older subjects -- Tufts study.

CALCIUM/VITAMIN D REDUCES BONE LOSS, FRACTURES IN OLDER PATIENTS, a three-year study by Bess Dawson-Hughes, MD, et al., Tufts University, concludes. Published in the Sept. 4 New England Journal of Medicine, the research shows that among 176 men and 213 women ages 65 and older and living at home, "dietary supplementation with calcium and vitamin D moderately reduced bone loss measured in the femoral neck, spine, and total body over the three-year study period and reduced the incidence of nonvertebral fractures," Dawson-Hughes and colleagues state. The study was funded by the National Institute on Aging under its Sites Testing Osteoporosis Prevention/Intervention Treatments (STOP/IT) initiative.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel